HEADER TRANSCRIPTION 16-SEP-15 5APK TITLE LIGAND COMPLEX OF RORG LBD COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, UNP RESIDUES 265-507; COMPND 5 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 6 GROUP F MEMBER 3, RAR-RELATED ORPHAN RECEPTOR C, RETINOID-RELATED COMPND 7 ORPHAN RECEPTOR-GAMMA, RORG; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 11 CHAIN: D; COMPND 12 FRAGMENT: UNP RESIDUES 480-492; COMPND 13 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 14 GROUP F MEMBER 3, RAR-RELATED ORPHAN RECEPTOR C, RETINOID-RELATED COMPND 15 ORPHAN RECEPTOR-GAMMA, RORG; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSCRIPTION, RORG LIGAND, RORG AGONIST, STRUCTURE-BASED DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,A.AAGAARD,F.NARJES REVDAT 3 14-FEB-18 5APK 1 JRNL REVDAT 2 03-FEB-16 5APK 1 JRNL REVDAT 1 25-NOV-15 5APK 0 JRNL AUTH R.I.OLSSON,Y.XUE,S.VON BERG,A.AAGAARD,J.MCPHEAT,E.L.HANSSON, JRNL AUTH 2 J.BERNSTROM,P.HANSSON,J.JIRHOLT,H.GRINDEBACKE,A.LEFFLER, JRNL AUTH 3 R.CHEN,Y.XIONG,H.GE,T.G.HANSSON,F.NARJES JRNL TITL BENZOXAZEPINES ACHIEVE POTENT SUPPRESSION OF IL-17 RELEASE JRNL TITL 2 IN HUMAN T-HELPER 17 (TH 17) CELLS THROUGH AN INDUCED-FIT JRNL TITL 3 BINDING MODE TO THE NUCLEAR RECEPTOR ROR GAMMA. JRNL REF CHEMMEDCHEM V. 11 207 2016 JRNL REFN ESSN 1860-7187 JRNL PMID 26553345 JRNL DOI 10.1002/CMDC.201500432 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.54 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 42530 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.240 REMARK 3 FREE R VALUE TEST SET COUNT : 2227 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.15 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.93 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3079 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2405 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2892 REMARK 3 BIN R VALUE (WORKING SET) : 0.2386 REMARK 3 BIN FREE R VALUE : 0.2700 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.07 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 187 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3912 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 303 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.49 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.25490 REMARK 3 B22 (A**2) : -3.25490 REMARK 3 B33 (A**2) : 6.50990 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.245 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.169 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.148 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.169 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.149 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4069 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5488 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1464 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 98 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 606 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4069 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 498 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4796 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.08 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.60 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.35 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5APK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1290065062. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42558 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 46.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.30 REMARK 200 R MERGE (I) : 0.16000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3L0L REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.17333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 86.34667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 64.76000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 107.93333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 21.58667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 243 REMARK 465 HIS A 244 REMARK 465 ASN A 245 REMARK 465 HIS A 246 REMARK 465 ASN A 247 REMARK 465 HIS A 248 REMARK 465 ASN A 249 REMARK 465 HIS A 250 REMARK 465 ASN A 251 REMARK 465 HIS A 252 REMARK 465 ASN A 253 REMARK 465 HIS A 254 REMARK 465 ASN A 255 REMARK 465 GLY A 256 REMARK 465 GLY A 257 REMARK 465 GLN A 487 REMARK 465 HIS A 488 REMARK 465 LEU A 489 REMARK 465 HIS A 490 REMARK 465 PRO A 491 REMARK 465 ILE A 492 REMARK 465 VAL A 493 REMARK 465 VAL A 494 REMARK 465 GLN A 495 REMARK 465 ALA A 496 REMARK 465 ALA A 497 REMARK 465 PHE A 498 REMARK 465 PRO A 499 REMARK 465 PRO A 500 REMARK 465 LEU A 501 REMARK 465 TYR A 502 REMARK 465 LYS A 503 REMARK 465 GLU A 504 REMARK 465 LEU A 505 REMARK 465 PHE A 506 REMARK 465 SER A 507 REMARK 465 MET B 243 REMARK 465 HIS B 244 REMARK 465 ASN B 245 REMARK 465 HIS B 246 REMARK 465 ASN B 247 REMARK 465 HIS B 248 REMARK 465 ASN B 249 REMARK 465 HIS B 250 REMARK 465 ASN B 251 REMARK 465 HIS B 252 REMARK 465 ASN B 253 REMARK 465 HIS B 254 REMARK 465 ASN B 255 REMARK 465 GLY B 256 REMARK 465 GLY B 257 REMARK 465 GLU B 258 REMARK 465 ASN B 259 REMARK 465 LEU B 260 REMARK 465 TYR B 261 REMARK 465 PHE B 262 REMARK 465 GLN B 263 REMARK 465 GLY B 264 REMARK 465 LEU B 501 REMARK 465 TYR B 502 REMARK 465 LYS B 503 REMARK 465 GLU B 504 REMARK 465 LEU B 505 REMARK 465 PHE B 506 REMARK 465 SER B 507 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 286 -60.64 77.22 REMARK 500 GLU A 435 62.84 -108.44 REMARK 500 GLN B 286 -62.33 76.47 REMARK 500 GLU B 435 62.99 -108.70 REMARK 500 PHE B 498 174.47 118.76 REMARK 500 PRO B 499 -159.77 -98.57 REMARK 500 GLU D 481 130.76 120.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 2-CHLORO-6-FLUORO-N-[4-[3-(TRIFLUOROMETHYL)PHENYL]SULFONYL-3,5-DIHYD REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 76E B 1501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 76E A 1487 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5APH RELATED DB: PDB REMARK 900 LIGAND COMPLEX OF RORG LBD REMARK 900 RELATED ID: 5APJ RELATED DB: PDB REMARK 900 LIGAND COMPLEX OF RORG LBD DBREF 5APK A 265 507 UNP P51449 RORG_HUMAN 265 507 DBREF 5APK B 265 507 UNP P51449 RORG_HUMAN 265 507 DBREF 5APK D 480 492 UNP P51449 RORG_HUMAN 480 492 SEQADV 5APK MET A 243 UNP P51449 EXPRESSION TAG SEQADV 5APK HIS A 244 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN A 245 UNP P51449 EXPRESSION TAG SEQADV 5APK HIS A 246 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN A 247 UNP P51449 EXPRESSION TAG SEQADV 5APK HIS A 248 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN A 249 UNP P51449 EXPRESSION TAG SEQADV 5APK HIS A 250 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN A 251 UNP P51449 EXPRESSION TAG SEQADV 5APK HIS A 252 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN A 253 UNP P51449 EXPRESSION TAG SEQADV 5APK HIS A 254 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN A 255 UNP P51449 EXPRESSION TAG SEQADV 5APK GLY A 256 UNP P51449 EXPRESSION TAG SEQADV 5APK GLY A 257 UNP P51449 EXPRESSION TAG SEQADV 5APK GLU A 258 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN A 259 UNP P51449 EXPRESSION TAG SEQADV 5APK LEU A 260 UNP P51449 EXPRESSION TAG SEQADV 5APK TYR A 261 UNP P51449 EXPRESSION TAG SEQADV 5APK PHE A 262 UNP P51449 EXPRESSION TAG SEQADV 5APK GLN A 263 UNP P51449 EXPRESSION TAG SEQADV 5APK GLY A 264 UNP P51449 EXPRESSION TAG SEQADV 5APK MET B 243 UNP P51449 EXPRESSION TAG SEQADV 5APK HIS B 244 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN B 245 UNP P51449 EXPRESSION TAG SEQADV 5APK HIS B 246 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN B 247 UNP P51449 EXPRESSION TAG SEQADV 5APK HIS B 248 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN B 249 UNP P51449 EXPRESSION TAG SEQADV 5APK HIS B 250 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN B 251 UNP P51449 EXPRESSION TAG SEQADV 5APK HIS B 252 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN B 253 UNP P51449 EXPRESSION TAG SEQADV 5APK HIS B 254 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN B 255 UNP P51449 EXPRESSION TAG SEQADV 5APK GLY B 256 UNP P51449 EXPRESSION TAG SEQADV 5APK GLY B 257 UNP P51449 EXPRESSION TAG SEQADV 5APK GLU B 258 UNP P51449 EXPRESSION TAG SEQADV 5APK ASN B 259 UNP P51449 EXPRESSION TAG SEQADV 5APK LEU B 260 UNP P51449 EXPRESSION TAG SEQADV 5APK TYR B 261 UNP P51449 EXPRESSION TAG SEQADV 5APK PHE B 262 UNP P51449 EXPRESSION TAG SEQADV 5APK GLN B 263 UNP P51449 EXPRESSION TAG SEQADV 5APK GLY B 264 UNP P51449 EXPRESSION TAG SEQRES 1 A 265 MET HIS ASN HIS ASN HIS ASN HIS ASN HIS ASN HIS ASN SEQRES 2 A 265 GLY GLY GLU ASN LEU TYR PHE GLN GLY ALA SER LEU THR SEQRES 3 A 265 GLU ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR SEQRES 4 A 265 ARG GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG SEQRES 5 A 265 GLN ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY SEQRES 6 A 265 TYR GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS SEQRES 7 A 265 ALA HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU SEQRES 8 A 265 PHE ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN SEQRES 9 A 265 ASN ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU SEQRES 10 A 265 VAL VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP SEQRES 11 A 265 ASN ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET SEQRES 12 A 265 GLU LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SEQRES 13 A 265 SER ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS SEQRES 14 A 265 PHE SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL SEQRES 15 A 265 LEU ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG SEQRES 16 A 265 LYS VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE SEQRES 17 A 265 HIS HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU SEQRES 18 A 265 ALA LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SEQRES 19 A 265 SER GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU SEQRES 20 A 265 HIS PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR SEQRES 21 A 265 LYS GLU LEU PHE SER SEQRES 1 B 265 MET HIS ASN HIS ASN HIS ASN HIS ASN HIS ASN HIS ASN SEQRES 2 B 265 GLY GLY GLU ASN LEU TYR PHE GLN GLY ALA SER LEU THR SEQRES 3 B 265 GLU ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR SEQRES 4 B 265 ARG GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG SEQRES 5 B 265 GLN ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY SEQRES 6 B 265 TYR GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS SEQRES 7 B 265 ALA HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU SEQRES 8 B 265 PHE ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN SEQRES 9 B 265 ASN ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU SEQRES 10 B 265 VAL VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP SEQRES 11 B 265 ASN ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET SEQRES 12 B 265 GLU LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SEQRES 13 B 265 SER ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS SEQRES 14 B 265 PHE SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL SEQRES 15 B 265 LEU ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG SEQRES 16 B 265 LYS VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE SEQRES 17 B 265 HIS HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU SEQRES 18 B 265 ALA LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SEQRES 19 B 265 SER GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU SEQRES 20 B 265 HIS PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR SEQRES 21 B 265 LYS GLU LEU PHE SER SEQRES 1 D 13 VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS PRO ILE HET 76E A1487 35 HET 76E B1501 35 HETNAM 76E 2-CHLORO-6-FLUORO-N-[4-[3-(TRIFLUOROMETHYL) HETNAM 2 76E PHENYL]SULFONYL-3,5-DIHYDRO-2H-1,4-BENZOXAZEPIN-7- HETNAM 3 76E YL]BENZAMIDE FORMUL 4 76E 2(C23 H17 CL F4 N2 O4 S) FORMUL 6 HOH *303(H2 O) HELIX 1 1 ASN A 259 GLN A 263 5 5 HELIX 2 2 SER A 266 CYS A 285 1 20 HELIX 3 3 ARG A 288 GLN A 295 1 8 HELIX 4 4 SER A 301 LYS A 311 1 11 HELIX 5 5 SER A 312 ARG A 337 1 26 HELIX 6 6 GLY A 340 LEU A 344 5 5 HELIX 7 7 CYS A 345 MET A 365 1 21 HELIX 8 8 GLY A 384 GLY A 392 5 9 HELIX 9 9 CYS A 393 ALA A 409 1 17 HELIX 10 10 SER A 413 ILE A 426 1 14 HELIX 11 11 GLU A 435 THR A 457 1 23 HELIX 12 12 ARG A 459 LEU A 466 5 8 HELIX 13 13 GLY A 470 PHE A 486 1 17 HELIX 14 14 SER B 266 CYS B 285 1 20 HELIX 15 15 ARG B 288 GLN B 295 1 8 HELIX 16 16 SER B 301 LYS B 311 1 11 HELIX 17 17 SER B 312 ARG B 337 1 26 HELIX 18 18 CYS B 345 MET B 365 1 21 HELIX 19 19 GLY B 384 GLY B 392 5 9 HELIX 20 20 CYS B 393 ALA B 409 1 17 HELIX 21 21 SER B 413 ILE B 426 1 14 HELIX 22 22 GLU B 435 THR B 457 1 23 HELIX 23 23 ARG B 459 LEU B 466 5 8 HELIX 24 24 PRO B 468 HIS B 488 1 21 HELIX 25 25 GLU D 481 HIS D 490 1 10 SHEET 1 AA 3 TYR A 369 ASN A 370 0 SHEET 2 AA 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SHEET 1 BA 3 TYR B 369 ASN B 370 0 SHEET 2 BA 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370 SHEET 3 BA 3 LYS B 381 GLY B 383 -1 O LYS B 381 N PHE B 378 CISPEP 1 PHE B 498 PRO B 499 0 4.61 SITE 1 AC1 15 TRP B 317 CYS B 320 HIS B 323 LEU B 324 SITE 2 AC1 15 VAL B 361 MET B 365 VAL B 376 PHE B 378 SITE 3 AC1 15 PHE B 388 LEU B 396 ILE B 397 ILE B 400 SITE 4 AC1 15 HIS B 479 LEU B 483 HOH B2082 SITE 1 AC2 14 TRP A 317 CYS A 320 ALA A 321 HIS A 323 SITE 2 AC2 14 LEU A 324 VAL A 361 VAL A 376 PHE A 378 SITE 3 AC2 14 PHE A 388 LEU A 396 ILE A 397 ILE A 400 SITE 4 AC2 14 HIS A 479 HOH A2069 CRYST1 99.750 99.750 129.520 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010025 0.005788 0.000000 0.00000 SCALE2 0.000000 0.011576 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007721 0.00000 MASTER 338 0 2 25 6 0 8 6 0 0 0 43 END